Page last updated: 2024-10-25

deferiprone and Experimental Radiation Injuries

deferiprone has been researched along with Experimental Radiation Injuries in 3 studies

Deferiprone: A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.
deferiprone : A member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia.

Research Excerpts

ExcerptRelevanceReference
" Dosing with DFP protected photoreceptors, decreasing the numbers of TUNEL-positive photoreceptors and increasing the number of surviving photoreceptors."1.38Systemic administration of the iron chelator deferiprone protects against light-induced photoreceptor degeneration in the mouse retina. ( Dunaief, JL; Hadziahmetovic, M; Song, D; Song, Y; Zhong, Y, 2012)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Boyd, P1
Hyde, DR1
Song, D1
Song, Y1
Hadziahmetovic, M1
Zhong, Y1
Dunaief, JL1
Fukuda, S1
Ikeda, M1
Anzai, K1
Suzuki, M1
Katoh, A1
Kontoghiorghes, GJ1

Other Studies

3 other studies available for deferiprone and Experimental Radiation Injuries

ArticleYear
Iron contributes to photoreceptor degeneration and Müller glia proliferation in the zebrafish light-treated retina.
    Experimental eye research, 2022, Volume: 216

    Topics: Animals; Animals, Genetically Modified; Apoptosis; Cell Proliferation; Deferiprone; Ependymoglial Ce

2022
Systemic administration of the iron chelator deferiprone protects against light-induced photoreceptor degeneration in the mouse retina.
    Free radical biology & medicine, 2012, Jul-01, Volume: 53, Issue:1

    Topics: Animals; Apoptosis; Deferiprone; Female; Fluorescent Antibody Technique; In Situ Nick-End Labeling;

2012
Radiation protection by deferiprone in animal models.
    Hemoglobin, 2006, Volume: 30, Issue:2

    Topics: Administration, Oral; Animals; Chelating Agents; Chelation Therapy; Deferiprone; Drug Evaluation, Pr

2006